223 related articles for article (PubMed ID: 6685703)
1. Results of long-term domiciliary dapsone (DDS) monotherapy for lepromatous leprosy in Gudiyatham Taluk, South India.
Almeida JG; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):385-6. PubMed ID: 6685703
[TBL] [Abstract][Full Text] [Related]
2. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
Almeida JG; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
[TBL] [Abstract][Full Text] [Related]
3. Follow-up of lepromatous (LL and BL) patients on dapsone (DDS) monotherapy after attainment of smear negativity in Gudiyatham Taluk, South India.
Almeida JG; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):382-4. PubMed ID: 6685702
[TBL] [Abstract][Full Text] [Related]
4. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.
Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of secondary dapsone resistance in Gudiyattam Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 1. Preliminary report.
Balraj V; Jesudasan K; Chacko CJ; Christian M; Taylor PM; Fritschi EP; Job CK
Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):397-401. PubMed ID: 7193654
[TBL] [Abstract][Full Text] [Related]
6. Relapse rates in lepromatous leprosy according to treatment regularity.
Almeida JG; Jesudasan K; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):16-20. PubMed ID: 3519802
[TBL] [Abstract][Full Text] [Related]
7. Trends in leprosy over fifty years in Gudiyatham Taluk, Vellore, Tamil Nadu.
Norman G; Raja Samuel Bhushanam JD; Samuel P
Indian J Lepr; 2006; 78(2):167-85. PubMed ID: 16927851
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the self administration of DDS in Gudiyatham Taluk.
Jesudasan K; George B; Chacko CJ; Taylor PM; Kurian PV; Job CK
Lepr India; 1976 Oct; 48(4 Suppl):668-76. PubMed ID: 1026802
[TBL] [Abstract][Full Text] [Related]
9. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP
Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722
[No Abstract] [Full Text] [Related]
10. The nose in lepromatous leprosy; bacteriological and histopathological studies of patients treated with dapsone monotherapy for varying periods of time.
Barton RP; Rees RJ; McDougall AC; Ellard GA
Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):58-67. PubMed ID: 7200473
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
12. Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
Kumar A; Balakrishnan S
Lepr India; 1983 Jul; 55(3):521-7. PubMed ID: 6656209
[TBL] [Abstract][Full Text] [Related]
13. Ocular complications in incident relapsed borderline lepromatous and lepromatous leprosy patients in south India.
Daniel E; Koshy S; Joseph GA; Rao PS
Indian J Ophthalmol; 2003 Jun; 51(2):155-9. PubMed ID: 12831146
[TBL] [Abstract][Full Text] [Related]
14. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
15. The contribution of "cure by dapsone monotherapy' to the reduction of prevalence of leprosy in the State of Orissa, India, 1983-1993.
Patnaik PK; McDougall AC
Indian J Lepr; 1996; 68(3):223-6. PubMed ID: 8889607
[TBL] [Abstract][Full Text] [Related]
16. The significance of dapsone (DDS)-resistant Mycobacterium leprae in untreated patients.
Almeida JG; Chacko CJ; Christian M
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):374-7. PubMed ID: 6685700
[TBL] [Abstract][Full Text] [Related]
17. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
18. Oral zinc as an adjunct to dapsone in lepromatous leprosy.
Mathur NK; Bumb RA; Mangal HN; Sharma ML
Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):331-8. PubMed ID: 6541200
[TBL] [Abstract][Full Text] [Related]
19. Association between regularity in dapsone (DDS) treatment and development of deformity.
Radhakrishna S; Nair NG
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
